NNNN
Anbio Biotechnology·NASDAQ
--
--(--)
--
--(--)
7.66 / 10
Outperform
Money flow analysis registers a sentiment score of 7.66/10, classified as good with positive trends in block, medium, and extra-large flows, despite negative small and large inflows. The fund-flow score of 7.66/10 aligns with the overall positive sentiment, indicating net inflows that support the stock's momentum. The absence of analyst coverage (ana_eval = -1) means the assessment relies solely on quantitative fund-flow data, which remains constructive. This combination of strong fund flows and bullish technicals enhances the likelihood of continued price appreciation.
Fund Flow Rating
What is the analyst consensus for NNNN?
- NNNN holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.66/10 (Outperform).
